Cephalon To Buy Swiss Drugmaker Mepha For $590M

Law360, New York (February 1, 2010, 1:58 PM EST) -- Cephalon Inc. has agreed to pay about $590 million (622.5 million Swiss francs) for the privately held Swiss pharmaceutical company Mepha AG, the companies announced Monday.

The companies anticipate that the deal will close within the next 12 weeks, pending certain closing conditions and clearing antitrust hurdles, they announced in a joint statement.

The deal will double the size of Pennsylvania-based Cephalon's international business and diversify its product lineup. The combined company will have a presence in 100 countries, and 30 percent of its sales will...
To view the full article, register now.